Susan Mugaba
51-59 Nakiwogo Road
Entebbe, C, Uganda
Entebbe, C, Uganda
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Preclinical Safety Evaluation of a Replication-Defective Canine Adenovirus Type 2 Vector-Based SARS-CoV-2 Vaccine Candidate in Murine Models.
Journal: Vaccines
Published: May 13, 2026
Practical guidelines for producing non-replicating canine adenovirus vectors.
Journal: PloS one
Published: August 21, 2025
Validation of high-throughput oxford nanopore technology for HIV-1 transmitted/founder virus identification.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 16, 2025
BonoboFlow: viral genome assembly and haplotype reconstruction from nanopore reads.
Journal: Bioinformatics advances
Published: August 03, 2024
Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.
Journal: Frontiers in immunology
Published: April 10, 2024
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.
Journal: The Lancet. Microbe
Published: March 22, 2024
Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations.
Journal: Frontiers in immunology
Published: December 03, 2023
Bacterial microbiome and host inflammatory gene expression in foreskin tissue.
Journal: Heliyon
Published: June 10, 2023
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin.
Journal: AIDS (London, England)
Published: June 08, 2023
Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 22, 2023
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy.
Journal: Frontiers in immunology
Published: March 10, 2023
Last Updated: 09/26/2026